CollPlant Biotechnologies (XTAE:CLGN) Days Sales Outstanding : 1.25 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CollPlant Biotechnologies Days Sales Outstanding?

CollPlant Biotechnologies's average Accounts Receivable for the three months ended in Dec. 2023 was ₪0.02 Mil. CollPlant Biotechnologies's Revenue for the three months ended in Dec. 2023 was ₪1.10 Mil. Hence, CollPlant Biotechnologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 1.25.

The historical rank and industry rank for CollPlant Biotechnologies's Days Sales Outstanding or its related term are showing as below:

XTAE:CLGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.3 Med: 36.94 Max: 2754.31
Current: 69.98

During the past 12 years, CollPlant Biotechnologies's highest Days Sales Outstanding was 2754.31. The lowest was 0.30. And the median was 36.94.

XTAE:CLGN's Days Sales Outstanding is ranked better than
52.13% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs XTAE:CLGN: 69.98

CollPlant Biotechnologies's Days Sales Outstanding declined from Dec. 2022 (14.14) to Dec. 2023 (1.25).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

CollPlant Biotechnologies Days Sales Outstanding Historical Data

The historical data trend for CollPlant Biotechnologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Days Sales Outstanding Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

46.85

27.03

12.83

170.21

0.30

CollPlant Biotechnologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															14.14	34.99	46.97	10,783.09	1.25

Competitive Comparison of CollPlant Biotechnologies's Days Sales Outstanding

For the Biotechnology subindustry, CollPlant Biotechnologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CollPlant Biotechnologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Days Sales Outstanding falls into.

CollPlant Biotechnologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CollPlant Biotechnologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.033	+	0)	/	1 )	/	40.263	*	365
=	0.033					/	40.263	*	365
=	0.30

CollPlant Biotechnologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.015	+	0)	/	1 )	/	1.099	*	365 / 4
=	0.015					/	1.099	*	365 / 4
=	1.25

CollPlant Biotechnologies (XTAE:CLGN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CollPlant Biotechnologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (XTAE:CLGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (XTAE:CLGN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CLGN:USA CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.